BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH)

CUSIP: 078771300

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
2,733,124
Share change
+70,126
Total reported value
$18,228,447
Price per share
$6.67
Number of holders
36
Value change
+$293,522
Number of buys
13
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 078771300?
CUSIP 078771300 identifies BLPH - BELLEROPHON THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) as of Q4 2020

As of 31 Dec 2020, BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,733,124 shares. The largest 10 holders included NEW MOUNTAIN VANTAGE ADVISERS, L.L.C., VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, Telemetry Investments, L.L.C., NORTHERN TRUST CORP, DAVENPORT & Co LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.